Changes in sodium levels, serving sizes, and calories in matched restaurant menu items (2016–2020) by sodium reduction or increase. by Caroline G. Middleton (22041479)

Subjects:

Host population bottlenecks decrease microbiome diversity. by Michael Ørsted (5926028)

Summary of the earliest time point for significant WD-induced changes in NASH-associated markers. by Melinda H. Spooner (6551933)

Subjects:

Validation of primary screen hits reveals compounds that recapitulate increased spheroid size (swell) or decreased MUC5AC in the lumen. by Pranjali Beri (14945400)

“…Compound 206 (1μM) significantly increased spheroid size relative to DMSO + CSE 3% control bronchospheres. …”

Magnitude of emission reduction. by Mohammed Qasim Shaheen (21417079)

Subjects:

Cephalometric measurement points. by Lijuan Liu (136685)

Subjects:

Shows the amount of emission reductions. by Mohammed Qasim Shaheen (21417079)

Subjects:

DataSheet_1_Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice.docx by Kawaljit Kaur (1496686)

Reduction of NPIs by >50% may result increased transmission and significant mortality. by Benjamin U. Hoffman (5470583)

Higher reward decreases three measures of response variability. by Zvi N. Roth (9611598)

Decrease of autoantibody levels in highly inflammatory NSG mice. by Henrika Jodeleit (4722312)

Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR. by Jordan A. Gunning (18143970)

Comparison of PCNA expression grades across different groups at various time points. by Jian-feng Li (8667645)

Subjects:

Comparison of mTOR expression grading among different groups at different time points. by Jian-feng Li (8667645)

Subjects:

Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test. by Maria Anna Donati (6735548)

Subjects:

Image_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.TIF by Britta Hanssen (4898155)

“…This investigation confirmed the disproportional decrease in muscle size and muscle strength around the knee and ankle joint in children with SCP, but also highlighted the large variability in the contribution of muscle size to muscle weakness.…”

Table_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…This investigation confirmed the disproportional decrease in muscle size and muscle strength around the knee and ankle joint in children with SCP, but also highlighted the large variability in the contribution of muscle size to muscle weakness.…”

Table_3_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…This investigation confirmed the disproportional decrease in muscle size and muscle strength around the knee and ankle joint in children with SCP, but also highlighted the large variability in the contribution of muscle size to muscle weakness.…”

Table_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…This investigation confirmed the disproportional decrease in muscle size and muscle strength around the knee and ankle joint in children with SCP, but also highlighted the large variability in the contribution of muscle size to muscle weakness.…”

Ppk1 levels are not affected by decreasing dendrite arbor size but are reduced when dendrite length increases. by Josephine W. Mitchell (17364781)